The National Biopharmaceutical International Innovation Park was opened and is expected to achieve an annual output value of more than 5 billion yuan.

Pharmaceutical Network Pharmaceutical Engineering: The National Biopharmaceutical International Innovation Park was officially opened in Tianjin Binhai High-tech Zone on This monthThe project covers an area of 10,000 square meters is expected to be put into use in the year can attract more than a family of enterprises to achieve annual output value of more than 100 million yuanIt is understood that the National Biopharmaceutical International Innovation Park will focus on innovative drugs and medical equipment and other industrial areas of side-building side investment at the same time planning product research and development, manufacturing and third-party industrial support platform to achieve clinical needs, research and development manufacturing, application development of close linkageThe public information shows that the overall strategic positioning of Tianjin Binhai High-tech Zone supports the development of Binhai New Area through the high gathering of global innovation elements and the high concentration of international innovation environment, the establishment and improvement of innovation network and the continuous emergence of innovation achievements and the spread of radiation to create and lead the trend of high-tech industry developmentThe biopharmaceutical industry is a very broad development prospect of chaoyang industryIn recent years, Tianjin Binhai High-tech Zone has been actively laying out the biopharmaceutical industryRelying on Tianjin Pharmaceutical Research Institute Co., Ltd., Chinese Academy of Medical Sciences Hematology Hospital Hematology Research Institute, Concord Stem Cell Genetic Engineering Co., Ltd., Heyuan Biotech Tianjin Co., Ltd., Tianjiu Regenerative Medicine Tianjin Technology Co., Ltd., Tianjin Jinyuan Medical Testing Laboratory Co., Ltdand a number of leading enterprises to accelerate the construction of "cell valley" cell extraction preparation, cell storage, quality control testing, research and development production, application transformation, cold chain logistics" cell industry chainSince the first half of this year, the innovation and development of biopharmaceutical enterprises in high-tech areas supported by favorable policies has been "speeding up"In the field of biomedicine research and development, Binhai High-tech Zone released the "Year Binhai New Area cell industry technology innovation work points" which mentioned an onthe cell, heyuan biology and so on to obtain a new class of clinical trial license; The purpose of the national biopharmaceutical international innovation park is to enhance the aggregate effect of the biopharmaceutical industry to accelerate the development of innovationIn addition to the project, the Biomedical Innovation Center was invested in the same partThe center covers an area of 10,000 square meters has Tianjin Pharmaceutical Research Institute investment special medical food projects, medical device platform and other projects signed into the project is expected to be put into operation by the end of the yearAccording to the goal set by Tianjin Binhai High-tech Zone for the next five years, we should focus on building a "special industry system" through the implementation of industrial cluster optimization projects around safe, independent and controllable industries and intelligent manufacturing, biomedicine and new economic servicesHigh-quality to build bio-pharmaceutical industry clusterGive full play to the leading enterprises to promote the development of new drug research and development, medical devices, modern Chinese medicine and other fields to strengthen the characteristics of the biopharmaceutical industryIt is reported that the next high-tech zone will focus on enhancing independent innovation capabilities around innovative drugs, medical equipment continued to focus on the advantages of the field to build a distinct industrial characteristics, rich elements of innovation, the industrial chain perfect bio-pharmaceutical industry gathering area